There is something almost paradoxical about EssilorLuxottica's stock market trajectory in 2026. The group continues to post sales figures most companies would envy — +11.7% at constant exchange rates in Q3 2025, +11.2% for the full year, and +10.8% again in Q1 2026. Yet over six months, its share price has erased more than 40% of its value from the November 2025 peak, pushing the group's market capitalisation from roughly €150 billion down to €86 billion.
This is not the story of a company in operational freefall. It is the story of a market that has fundamentally reassessed the quality and sustainability of that growth. Understanding why means understanding how the traditional eyewear industry now collides with the economics of consumer technology.
EssilorLuxottica stock in 2026: strong sales, a share price in decline
To grasp the problem, it helps to look at the official figures without distortion. EssilorLuxottica is not losing customers or closing stores. Across the three most recent reporting milestones, the commercial momentum remains real.
In Q3 2025, the group reported €6.867 billion in revenue, up 11.7% at constant exchange rates. The full year 2025 closed at €28.491 billion, growing 11.2% at constant rates — but with an adjusted operating margin of 16.0% at constant exchange rates, down 70 basis points year on year. In Q1 2026, sales reached €7.127 billion, or +10.8% at constant exchange rates. In published terms — what shareholders actually receive — growth falls to just +4.1%. In North America, the gap is even more striking: +12.5% at constant rates versus only +1.5% as reported.
That chasm between underlying and reported growth is one of the first keys to the story. It reflects the drag exerted by a weak US dollar on a company that generates a significant share of its revenues in non-European currencies.
October 2025: the smart glasses euphoria
To understand the fall, one must first understand the rise. On 17 October 2025, EssilorLuxottica's shares surged roughly 14% in a single session, following an exceptional Q3 report. The driver of that euphoria? The Ray-Ban Meta connected glasses, which added more than four percentage points to quarterly revenue growth on their own.
The market read this as the emergence of a new, massive growth axis at the intersection of consumer tech and optics. The idea took hold that EssilorLuxottica was no longer simply the world's leading eyewear company — it was potentially becoming a central player in mass-market wearable computing. Valuations ran higher, the stock hit record levels, and the group's precise 2026 guidance (€27–28 billion in revenue, 19–20% adjusted operating margin) suddenly looked achievable, even conservative.
Six months later, that story had become considerably harder to tell.
What the market is actually repricing
The correction is not about sales. It is about what the market is now willing to pay for those sales — what analysts call a valuation de-rating. The stock is not collapsing because the accounts are catastrophic; it is falling because the market refuses to assign the same earnings multiple it did in autumn 2025.
The heart of the problem lies in the connected glasses themselves. What the scaling of Ray-Ban Meta — including the prescription-compatible version — has started to reveal is that this category drives revenue higher while compressing margins. Smart glasses are simply not as profitable as traditional optical frames. Investors have begun questioning the price trajectory, product mix, and profitability path as volumes build.
In October 2025, the investment story was simple and exciting. By April 2026, it had become a portfolio of complex strategic options, some of which — med-tech, audio, retail expansion in Thailand — will take years to monetise. Markets rarely pay the same multiple for a strategic option and for visible earnings growth.
The guidance "soft reset": the decisive signal
The second major factor involves a language change that appeared minor but was read by the market as a telling admission. Through Q3 2025, EssilorLuxottica was reiterating a precise, quantified 2022–2026 target: mid-single-digit annual growth, €27–28 billion in revenues, and a 19–20% adjusted operating margin by end-2026.
In February 2026, when the annual results were released, this framework was replaced with significantly looser language: "solid" revenue growth and operating profit growing "broadly in line" over five years. In April, at the Q1 2026 release, the same outlook was confirmed — but without any return to a concrete figure.
For a stock whose valuation rested on a clearly defined margin trajectory, that loss of precision weighed almost as heavily as an explicit guidance cut. The market did not punish a profit warning — it punished the absence of visibility.
The dollar effect and US tariff shock
External headwinds have compounded an already fragile situation. At the Annual General Meeting on 28 April 2026, CEO Francesco Milleri explicitly listed the drivers of the stock's pressure: US tariffs, a weak dollar, geopolitical conflicts, and competition in smart glasses. CFO Stefano Grassi quantified the American tariff impact at €300 million on the 2025 fiscal year.
The FX effect is visible across every line of the Q1 2026 release. The gap between constant-currency growth (+10.8%) and reported growth (+4.1%) represents approximately six points of revenue erased by currency movements alone. In North America — the strategic market for both connected glasses and premium optical brands — that gap reaches eleven points.
Competitive risk in wearables
The third structural pressure is the growing competitive threat in the smart glasses category. EssilorLuxottica is no longer alone on this ground. The Kering Eyewear x Google partnership on Android XR has clearly signalled that the luxury industry intends to contest this territory rather than cede it to Ray-Ban and Meta.
The Wall Street Journal reported that smart glasses growth had slowed to a mid-single-digit pace in early 2026, with supply chain bottlenecks identified particularly in Europe. Meanwhile, the Q1 2026 release noted that more than half of EMEA points of sale were still not covered by the connected glasses distribution rollout — a sign of residual potential, but also evidence that the near-linear expansion scenario the market priced in last autumn was overoptimistic.
What analysts are saying
The sell-side picture is consistent without being catastrophic. Publicly visible revisions are tilting downward on price targets, without signalling fundamental collapse.
UBS cut its target from €347 to €315 in April 2026 while maintaining a buy rating, arguing that the current valuation does not yet reflect any success from smart glasses. Bernstein held a "Market Perform" at €250, citing caution on competitive disruption risk in wearables and noting that EssilorLuxottica is trading at multiples more typical of a technology stock. Kepler Cheuvreux described the implied 2026 growth trajectory as "demanding." Morgan Stanley concluded that April delivered nothing worse than Q1, a mild reassurance that changed nothing structurally.
The overall picture is one of valuation compression in progress, not capitulation — but without a clear near-term catalyst for re-rating.
Insiders, governance and litigation
Insider transaction flows do not support a narrative of internal panic. AMF regulatory filings show a small disposal by Nathalie von Siemens (485 shares in February 2026), but also purchases by Sébastien Brown (175 shares in March) and, more significantly, an acquisition by Bpifrance Participations of 253,200 shares on 24 April 2026 at an average price of €192.33. The group itself repurchased 89,263 of its own shares on the same day. Nothing here resembles a wave of insider selling ahead of a hidden profit warning.
On the legal front, the principal new risk is a patent infringement lawsuit filed on 23 January 2026 by Solos Technology against both Meta and EssilorLuxottica in a US court over smart glasses technology. The case is potentially costly but has not yet moved markets materially. Conversely, older consumer antitrust proceedings were dismissed in September 2025 — a neutralisation rather than a reopening.
On governance, the Financial Times and Reuters reported in March–April 2026 on negotiations by Leonardo Maria Del Vecchio to buy out his siblings' stakes in the controlling holding company — background noise rather than a direct driver of the sell-off.
The comparative lesson: Safilo and LVMH
Two sector comparisons sharpen the picture of EssilorLuxottica's specific situation.
Safilo, a direct competitor listed in Milan, published its Q1 2026 with a slight revenue decline at reported rates, also hit by currency moves. But its gross margin expanded to 62.0% and its adjusted EBITDA margin rose to 13.6%. The stock gained 5.75% on results day. The market still forgives a weak top line when margin discipline holds. That is precisely what is missing from the EssilorLuxottica investment case today.
LVMH provides another reference point. The luxury group's Q1 2026 came in at -6% in reported terms and just +1% organically, hurt by geopolitical headwinds and lower tourist spending — the stock was down around 27% year-to-date by 14 April. Macro pressure on European premium assets is real and shared. But EssilorLuxottica's correction carries an additional, specific layer: the repricing of the wearables narrative and the compression of the valuation premium.
Hierarchy of causes
Ranking the factors by relative weight produces a clear reading. The compression of the multiple following the AI glasses euphoria is the primary cause, accounting for roughly 35% of the decline: the stock rose to record levels on a technological expansion narrative, then corrected by more than 40% without any collapse in underlying sales.
Disappointment on the margin trajectory and the guidance soft reset accounts for around 25%: the 2025 adjusted operating margin at 16.0% falls well short of the 19–20% previously targeted for end-2026, and the substitution of a quantified target with a vague five-year framework eroded investor conviction.
FX, US tariffs and geopolitical macro contributes roughly 18%, while competitive risk and execution friction in smart glasses explains around 12% of the sell-off. Finally, the technical feedback loop — a break below both 50-day and 200-day moving averages, a 52-week low of €168.65 on 5 May 2026, above-average volume on the post-Q1 session — accounts for the remaining 10%.
What the investment case still needs to prove
The market is not selling EssilorLuxottica because its accounts are bad. It is selling a company that must demonstrate three things simultaneously: that its core brands — Oakley, Ray-Ban and Oliver Peoples — continue to anchor the traditional optical business; that smart glasses can become a genuine earnings driver, not just a revenue line; and that the FX and tariff shock will not permanently prevent a structural margin recovery. Until that triple proof is delivered, the valuation remains exposed to any disappointment.
Sources
- EssilorLuxottica — Q1 2026 Revenue (GlobeNewswire)
- EssilorLuxottica — Q4/Full Year 2025 Results (GlobeNewswire)
- EssilorLuxottica faces test to grow smart glass sales without hurting margins (Reuters, 21 April 2026)
- EssilorLuxottica slips as doubts linger over smart glasses growth (Reuters, 23 April 2026)
- EssilorLuxottica CEO confident share price will recover (Reuters, 28 April 2026)
- EssilorLuxottica Shares Fall as Investors Weigh Impact of Smartglasses (Wall Street Journal)
